Delivery Order SPE2DB22D6029-SPE2DB24FU0PM

Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,814.29, is for the supply of Bupropion HCL XL 300 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,563,337,776 units of the prescription drug Bupropion HCL XL 300 mg tablets. The delivery order has a firm fixed price of $60,566.68 and an ultimate completion date of January 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide 4,563,618,722 Bupropion HCL XL 300 mg tablets in quantities of 500 per bottle. The $20,759.83 delivery order has a completion date of February 12, 2024 and was awarded on February 9, 2024. This award is part of a larger indefinite delivery contract (IDC) that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The order, valued at $18,952.56, is for the supply of Bupropion HCL XL 150 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on this order, with no indicated set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,489,505 units of Bupropion HCL XL 150 mg tablets in 500-count bottles. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4,563,862,693 units of Bupropion HCL XL 150 mg tablets, with a potential value of $27,368.94 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $28,378.07 order is for the supply of Bupropion HCL XL 300 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for 500 units of Bupropion HCL XL 150 mg tablets, with a potential value of $12,963.91 and a completion date of February 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FU0PM
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The $1,370.20 award is for the delivery of 4,564,253,884 units of Bupropion HCL XL 300 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 7/12/24, 10:46 AM